ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Bunn To Succeed Norton As ASCO President, Tempero Is President-Elect

April 26, 2002

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Hudis’s Address At ASCO 2014: On Value & Commitment

June 6, 2014

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991